Build a sustainable vaccines industry with synthetic biology - A summary (2021)

The vaccine industry has been in a difficult situation for a long time. Spending on vaccines is insignificant compared to other interventions. Five multinationals produce 80% of vaccines. There are poor financial returns to the vaccine industry and high production and R&D costs. Manufacturing facilities are capital intensive. Lower-income countries buy vaccines when they are more affordable. Before that, manufacturing costs are covered by vaccine sales in high-income countries.

a very tall building in the middle of a foggy sky. Photo by Aleksandr Popov, Unsplash.

_________________________________

Click on the image to open the article in PDF format.

This website is using cookies to provide a good browsing experience

These include essential cookies that are necessary for the operation of the site, as well as others that are used only for anonymous statistical purposes, for comfort settings or to display personalized content. You can decide for yourself which categories you want to allow. Please note that based on your settings, not all functions of the website may be available.

This website is using cookies to provide a good browsing experience

These include essential cookies that are necessary for the operation of the site, as well as others that are used only for anonymous statistical purposes, for comfort settings or to display personalized content. You can decide for yourself which categories you want to allow. Please note that based on your settings, not all functions of the website may be available.

Your cookie preferences have been saved.